Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 24 min 38 sec ago

Inivata Boosts Executive Team With Appointment of Clive Morris as Chief Medical Officer

Wed, 05/25/2016 - 13:48
CAMBRIDGE, England, May 25, 2016 -- (Healthcare Sales & Marketing Network) -- Inivata, a global clinical cancer genomics company employing the precision of circulating tumour DNA (ctDNA) analysis to improve personalised healthcare in oncology, today annou...
Diagnostics, Personnel
Inivata Limited, ctDNA analysis, ctDNA, cancer genomics

Elekta Wins Public Tender to Deliver Advanced Cancer Care Solutions to New Karolinska Solna (NKS)

Wed, 05/25/2016 - 13:43
STOCKHOLM--(Healthcare Sales & Marketing Network)--Stockholm County Council (Sweden), announced today that Elekta has been awarded the public tender to exclusively equip the Radiation Therapy Department of its new, flagship hospital, the New Karolinska Sol...
Devices, Oncology, Neurosurgery
Elekta, radiation therapy, radiosurgery, brachytherapy

Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients

Wed, 05/25/2016 - 13:35
New test standardizes CMV testing for both solid organ and hematopoietic stem cell transplant recipients PLEASANTON, Calif., May 25, 2016 -- (Healthcare Sales & Marketing Network) -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the United States ...
Diagnostics, FDA
Roche Group, cytomegalovirus

Cynosure Receives FDA Clearance to Market New PicoSure(R) Energy Delivery System for Tattoos and Pigmented Lesions

Tue, 05/24/2016 - 15:13
Shipments of New 1064 nm Wavelength to Begin in the Second Half of 2016 WESTFORD, Mass., May 24, 2016 -- (Healthcare Sales & Marketing Network) -- Broadening its product platform for tattoo removal and skin revitalization, Cynosure, Inc. (CYNO) today a...
Devices, Dermatology, FDA
Cynosure, PicoSure, picosecond laser, tattoo

Amplyx Pharmaceuticals Appoints Paul C. Grint, M.D., to Board of Directors

Tue, 05/24/2016 - 15:10
SAN DIEGO, May 24, 2016 -- (Healthcare Sales & Marketing Network) -- Amplyx Pharmaceuticals today announced the appointment of Paul C. Grint, M.D., to its Board of Directors. Dr. Grint, president and CEO, Regulus Therapeutics, joined Regulus in June 2014 ...
Biopharmaceuticals, Personnel
Amplyx Pharmaceuticals, Candida, Aspergillus

Allergan Announces FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0%

Tue, 05/24/2016 - 15:07
Potential Treatment for Patients with Facial Erythema (Redness) Associated with Rosacea Allergan Expects PDUFA Date in First Half 2017 DUBLIN, May 24, 2016 -- (Healthcare Sales & Marketing Network) -- Allergan plc (AGN) today announced that the New ...
Biopharmaceuticals, Dermatology, FDA
Allergan, Oxymetazoline, rosacea

Centinel Spine(TM) Expands STALIF(R) Internationally

Tue, 05/24/2016 - 13:01
NEW YORK, May 24, 2016 -- (Healthcare Sales & Marketing Network) -- Centinel Spine, Inc., (Centinel Spine), the pioneer of Stand-Alone, No-Profile®, Integrated Interbody™ fusion devices, expands its MIDLINE II-Ti product family, a Ti-ACTIVE™ coated, N...
Devices, Orthopaedic, Neurosurgery
Centinel Spine, Interbody fusion device, MIDLINE II-Ti, spine surgery

Interventional Spine, Inc. announces FDA Clearance of Lordotic Opticage(TM)

Tue, 05/24/2016 - 12:52
IRVINE, Calif., May 24, 2016 -- (Healthcare Sales & Marketing Network) -- Interventional Spine, Inc. announced today FDA clearance of its 80 Lumbar Lordotic Opticage™ Expandable Intervertebral Body Fusion Device. This device joins the Interventional Spine...
Devices, Orthopaedic, Neurosurgery, FDA
Interventional Spine, Lordotic Opticage, Interbody Fusion Devices, spine surgery

NuVasive Launches Next Generation Biologics Technology

Mon, 05/23/2016 - 18:51
FDA Cleared Synthetic Bone Graft With Novel Surface Structure That Promotes Bone Formation SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - NuVasive, Inc. (NUVA), a leading medical device company focused on transforming spine surgery with minimal...
Devices, Orthopaedic, Neurosurgery, Product Launch
NuVasive, AttraX Putty, synthetic bone graft, spine surgery

Interpace Diagnostics Presents New Clinical Utility Data at Digestive Disease Week

Mon, 05/23/2016 - 14:03
Dr. James Farrell of Yale University Presents Key Findings from Analysis of 13,000 Patient Database SAN DIEGO, May 23, 2016 -- (Healthcare Sales & Marketing Network) -- Interpace Diagnostics Corp. (IDXG), a company that provides clinically useful molec...
Diagnostic, Gastroenterology, Oncology
Interpace Diagnostics, PancraGEN, pancreatic cancer

Egalet Settles Patent Litigations with Purdue Pharma

Mon, 05/23/2016 - 13:56
No financial obligations to either party WAYNE, Pa., May 23, 2016 -- (Healthcare Sales & Marketing Network) -- Egalet Corporation (EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and ...
Biopharmaceuticals, Litigation
Egalet Corporation, Purdue Pharma, OXAYDO

OncoSec Announces $10 Million At-The-Market Registered Direct Offering

Mon, 05/23/2016 - 13:50
SAN DIEGO, May 23, 2016 -- (Healthcare Sales & Marketing Network) -- OncoSec Medical Incorporated ("OncoSec") (ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that it has entered into a definitive agree...
Biopharmaceuticals, Oncology, Venture Capital
OncoSec Medical, ImmunoPulse

Zambon Launches Xadago(R) (Safinamide) in the U.K. for Patients with Mid- to Late-Stage Parkinson’s Disease

Mon, 05/23/2016 - 13:42
Zambon today announces the availability in the U.K. of Xadago® (safinamide) for the treatment of adult patients with idiopathic Parkinson’s disease (PD) as an add-on therapy to a stable dose of Levodopa (L-dopa) alone or in combination with other Parki...
Biopharmaceuticals, Neurology, Product Launch
Newron Pharmaceuticals, Zambon, Xadago, Parkinson’s disease

Surgical Specialties Corporation Announces Approval of Expanded Use for BioSentry(TM) Track Sealant System in Europe

Mon, 05/23/2016 - 13:33
BRAINTREE, Mass., May 23, 2016 -- (Healthcare Sales & Marketing Network) -- Surgical Specialties Corporation (Surgical Specialties), a leading provider of branded, private label, and OEM medical devices for advanced surgery, wound closure, ophthalmology, ...
Devices, Regulatory
Surgical Specialties Corp, BioSentry, Track Sealant System

Neuralstem Announces Plan of Reorganization to Further Align Business with Strategic Intent

Fri, 05/20/2016 - 13:40
GERMANTOWN, Md., May 20, 2016 -- (Healthcare Sales & Marketing Network) -- Neuralstem, Inc. (CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell technology, announced a corporate r...
Regenerative Medicine, Neurology
Neuralstem, stem cell, amyotrophic lateral sclerosis

Avalon Ventures and COI Pharmaceuticals Announce First Milestones for Sitari Pharmaceuticals and Silarus Therapeutics and Formation of Eighth Company

Fri, 05/20/2016 - 13:33
Under the expanded collaboration between Avalon Ventures and GSK, eighth company, PDI Therapeutics, is launched to develop novel immuno-oncology therapies SAN DIEGO, May 20, 2016 -- (Healthcare Sales & Marketing Network) -- Avalon Ventures ("Avalo...
Biopharmaceuticals, Venture Capital
COI Pharmaceuticals, GlaxoSmithKline, Sitari Pharmaceuticals, Silarus

Otonomy Announces Assignment of C Code and Pass-Through Payment Status for OTIPRIO(TM)

Fri, 05/20/2016 - 13:26
SAN DIEGO, May 20, 2016 -- (Healthcare Sales & Marketing Network) -- Otonomy, Inc. (OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that t...
Biopharmaceuticals, Reimbursement
Otonomy, OTIPRIO, ciprofloxacin otic

EndoChoice(R) Launches Third Generation Fuse(R) Full Spectrum Endoscopy(R) System

Fri, 05/20/2016 - 13:16
New Fuse Generation 3 to be Unveiled at DDW® 2016 and the SGNA 43rd Annual Course ALPHARETTA, Ga., May 19, 2016 -- (Healthcare Sales & Marketing Network) -- EndoChoice Holdings, Inc. (NYSE: GI) announced today the full market release of its Generat...
Devices, Gastroenterology, Product Launch
EndoChoice, Endoscopy Fuse, Endoscopy

Elekta Surpasses One Million Patients Treated with Leksell Gamma Knife

Thu, 05/19/2016 - 18:20
Most clinically proven and comprehensively studied stereotactic radiosurgery and radiation therapy platform with more than 2,800 peer-reviewed journal articles published to date STOCKHOLM, May 19, 2016 -- (Healthcare Sales & Marketing Network) -- At th...
Devices, Oncology, Neurosurgery
Elekta, Leksell, Gamma Knife, radiosurgery, radiotherapy

Pain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY(R)

Thu, 05/19/2016 - 18:18
August 5th is FDA’s Tentative Date for Advisory Committee Meeting No Change to PDUFA Date AUSTIN, Texas, May 19, 2016 -- (Healthcare Sales & Marketing Network) -- Pain Therapeutics, Inc. (PTIE) announced today that an Advisory Committee of the U.S. F...
Biopharmaceuticals, FDA
Pain Therapeutics, REMOXY, oxycodone

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong